Life Sciences
Catalina Pharma, Inc.
Year
2017
Catalina Pharma is developing a TRPV1-inhibitor as treatment of anesthesia-induced hypothermia.
Website
Company Status
Active
U of A Inventors
Amol Patwardhan
Frank Porreca
Andrej Romanovsky
College
College of Medicine - Tucson, College of Pharmacy